Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,230 total articles
UnitedHealth ($UNH) is showing technical signs of stabilization after a difficult 2025. Fundamentals still look solid - market cap about $259B, free cash flow roughly $17.4B and EV/EBITDA near 10 - but regulatory and cost pressures leave upside capped until execution visibly improves. This trade idea outlines a guarded, short-biased swing to captur…
Zeta's acquisition of Marigold gives the company more addressable data and product depth at a reasonable enterprise value. The combination improves near-term cash generation and raises the upside for a mid-term trade. Entry at $17.90, stop at $16.25, target $22.50 — mid-term (45 trading days) thesis with a medium risk profile.
PPC sits close to its 52-week low with a sub-8x P/E, healthy free cash flow and a growing prepared-foods franchise. Technicals show oversold conditions and elevated short activity, offering a defined-risk long setup. This is a mid-term trade (45 trading days) aiming for mean reversion toward the 50-day band while keeping downside protection tight.
UnitedHealth Group ($UNH) trades at a valuation that discounts much of the company's Optum-driven long-term optionality. With free cash flow of $17.37B, an enterprise value of roughly $309B, and EV/EBITDA near 10x, the risk/reward favors accumulation. This trade idea lays out an entry at $285.86, a stop at $250.00, and a 180-day target of $360.00 a…
UnitedHealth ($UNH) is a beaten-down market leader trading near $285.50 with a market cap of about $259.1B. The core thesis: Optum's accelerated adoption of predictive analytics, workflow automation, and pharmacy management AI can materially restore margins and free cash flow, creating an asymmetric reward-to-risk trade over the next 45 trading day…
American Outdoor Brands (AOUT) trades like a small-cap beaten down by inventory/tariff noise and headline risk, but the business still shows margin resiliency, no debt and a sub-$110M market cap. This trade buys a tactical pullback with a defined stop and a mid-term target that captures rerating potential if sales normalize and guidance is reinstat…
Ares Management (ARES) just went ex-dividend with a meaningful payout bump and has been adding assets via M&A, lifting AUM toward record levels. The stock trades near $101 after a sharp sector-wide selloff tied to AI and private-credit jitters. With FCF north of $4.4B, a manageable P/E in the high 30s, and an immediate yield of roughly 4.4%, this i…
MP Materials controls critical U.S. rare-earth supply at Mountain Pass and is transitioning from a miner to an integrated producer of refined oxides and magnet precursors. The balance sheet supports growth, but the stock already carries a premium. This trade idea lays out an entry at $59.50, a $80 target and a $50 stop, sized for a mid-term swing (…
Credo Technology is printing revenue growth few hardware names can match and commanding enterprise-level margins from its Active Electrical Cables and SerDes chiplets. At $118, the market is assigning a premium multiple but is still underestimating near-term revenue compounding and product-led margin expansion. This trade targets a run toward $190 …
Boyd Gaming (BYD) trades at a low multiple relative to cash flow and peers, while incremental wins in online and racing operations create a playbook for international expansion. This trade idea outlines a swing-long entry with clear targets, stop, catalysts and risks tied to execution and macro sensitivity.
Incyte trades at a roughly $18.5B market cap with solid free cash flow and low leverage. Recent clinical noise has pressured the stock into the mid-$90s, creating a defined risk/reward for a swing trade into 2026 readouts and commercial updates. This plan buys a post-pullback entry, limits downside with a clear stop, and targets recapture toward pr…
Carlyle (CG) is getting punished largely on fears around private credit liquidity and mark-to-market pressure. Those concerns look priced in: Carlyle trades at a reasonable valuation (EV/EBITDA ~8.8), yields ~3.1%, generates ~$1.48B of free cash flow and carries modest leverage (debt/equity ~0.52). I upgrade to Buy and lay out an entry at $46.38, a…
CoreWeave is scaling into one of the largest specialized AI cloud providers. After 168% revenue growth in 2025 and a $66.8B backlog, the company is trading well below its long-term upside if it executes. This trade is for disciplined contrarians: buy near $86.46, stop at $65, target $150 across a 180 trading-day horizon, and size accordingly given …
Amneal's stock has pulled back from its 52-week high as near-term revenue growth looks muted. The balance sheet oddities and high P/E are real, but $270M in free cash flow, an EV/EBITDA near 9.9, and two high-impact pipeline opportunities (CREXONT and an omalizumab biosimilar) make a structured long trade attractive for the mid-term trader.
SoFi offers a high-conviction trade setup after CEO Anthony Noto's $1M stock purchase and a deepened Mastercard partnership for SoFiUSD. Fundamentals show rapid customer and revenue growth, improving profitability, but the stock still trades at a premium to last year's fundamentals. This idea lays out an entry, stop, targets and the reasons to own …
CTMX popped to a 52-week high on massive volume as investors price in clearer evidence that CytomX's Probody platform is delivering conditionally activated activity in tumors. Fundamentals remain mixed, but the technical breakout, rising short-covering, and upcoming clinical readouts make a disciplined long trade attractive for a mid-term swing.
Sterling Infrastructure rallied after a strong quarter and continues to look like a solid pick-and-shovel play into data center and transportation buildouts. Healthy free cash flow, low leverage, and a pivot toward higher-margin e-infrastructure work support upside, while valuation is rich but not extreme for a growth-infrastructure story. Trade pl…
Eledon Pharmaceuticals' anti-CD40L antibody tegoprubart (AT-1501) is showing meaningful clinical momentum as a potential alternative to calcineurin inhibitors in kidney transplantation. With positive Phase 2 BESTOW data, real-world use in a genetically modified pig kidney transplant, and a strengthened balance sheet from a $57.5M financing, ELDN lo…
Monro (MNRO) has been punished for margin hits and restructuring costs, but fundamentals and cash generation argue the stock can recover from an oversold setup. At roughly $15.30 and a market cap near $459M, Monro trades below book and at cheap cash-flow multiples while still producing meaningful free cash flow and a high dividend yield. This trade…
Nvidia's expected major GTC 2026 announcements for the Rubin platform and related AI infrastructure could be the catalyst that reconnects the shares with fundamentals. With revenue momentum, massive free cash flow and a still-elevated but reasonable multiple versus growth, this trade targets a mid-term swing into the event-driven rerating while lim…
Nebius' five-year, up-to-$27 billion commitment from Meta is the clearest proof-of-concept yet that hyperscalers will outsource massive AI capacity built around NVIDIA hardware. That contract, paired with Nebius' other wins, should underpin multi-year demand for NVIDIA's data-center GPUs, supporting further multiple expansion from today's levels. T…
Elliott's $1 billion convertible into Pinterest, plus an accelerated repurchase plan and a $3.5 billion buyback authorization, changes the near-term math. With a market cap near $11.8B, FCF roughly $1.25B and a P/S ~2.76, this is a tactical long on activist-backed cash returns. Entry, stop and target provided for a 45-trading-day swing trade.
MercadoLibre (MELI) combines e-commerce scale with a fast-growing fintech engine. Recent weakness has pulled the stock near key support while fundamentals - double-digit revenue growth, strong free cash flow, and expanding fintech adoption - remain intact. This trade idea lays out a long trade with clear entry, stop and target, plus catalysts and r…
SoFi is actively transforming from a balance-sheet-heavy lender to a capital-light fintech operator. Management is leaning into technology-platform revenue, a stablecoin partnership with Mastercard, and higher-margin financial-services products. That pivot reduces credit and interest-rate sensitivity while keeping revenue growth optionality. The st…
Super Micro (SMCI) has been volatile but the setup today looks like a discount on a company that still benefits from triple-digit AI-driven revenue growth. At roughly $18.9B market cap, a stabilizing margin story and cleaner customer diversification can re-rate the stock. This trade targets a mid-term stabilization window where downside is limited …
